| Bioactivity | SARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for the research of SARS-CoV-2 diseases[1]. |
| Name | SARS-CoV-2 3CLpro-IN-2 |
| CAS | 2765088-93-3 |
| Formula | C21H18F5N5O4 |
| Molar Mass | 499.39 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Tyndall JDA. S-217622, a 3CL Protease Inhibitor and Clinical Candidate for SARS-CoV-2. J Med Chem. 2022 May 12;65(9):6496-6498. |
SARS-CoV-2 3CLpro-IN-2
CAS: 2765088-93-3 F: C21H18F5N5O4 W: 499.39
SARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.